Wall Street Journal investigative reporter John Carreyrou recounts some of the more unusual experiences he had while uncovering the story of Theranos's business practices. Home Browse Series Live ...

Theranos, the $9 billion healthcare startup, went to lengths to try to kill a damning report in the Wall Street Journal. The paper spoke to former Theranos employees, their families, a number of ...

Christopher Weaver is a reporter at The Wall Street Journal. He joined the Journal in 2011 to cover U.S. healthcare ... the blood-testing company Theranos, abuses at the U.S. Indian Health Service ...

Theranos was valued in the billions of dollars based on the promise to test blood using just a few drops. The Silicon Valley ...

Following a series of articles by the Wall Street Journal, Theranos’ technologies have been called into question, leading to multiple setbacks. Theranos’ troubles became public in October 2015 ...

Last October, The Wall Street Journal published a now-famous story that brought up concerns over how Theranos' blood tests were run and how accurate they were. Four months before that story was ...

A Wall Street Journal report published Thursday alleged that Theranos, the $10-billion health startup whose blood tests can allegedly be done with a single drop, has a few problems. In a follow-up ...

Meghan Bobrowsky is a technology reporter in The Wall Street ... the Journal in 2021, Meghan has reported on Elon Musk’s bid and subsequent takeover of Twitter, the criminal trial of Theranos ...